Skip to main content
SpringerLink
Log in

The Liver

  • Chapter
  • First Online:
Atlas of Toxicological Pathology

  • 2014 Accesses

Abstract

Importance of hepatotoxicity in toxicity studies is briefly discussed. Various induced lesions occurring in the liver of experimental animals, such as degeneration, necrosis, inclusions, pigmentation, hypertrophy, hyperplasia, and tumours, are illustrated, and their relative importance is discussed. Significance of adaptive responses is also discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Cullen JM. Mechanistic classification of liver injury. Toxicol Pathol. 2005;33:6–8.

    Article  CAS  PubMed  Google Scholar 

  2. Boobis AR, Cohen SM, Doerrer NG, Galloway SM, Haley PJ, Hard GC, et al. A data-based assessment of alternative strategies for identification of potential human cancer hazards 2. Toxicol Pathol. 2009;37:714–32.

    Article  CAS  PubMed  Google Scholar 

  3. Carmichael N, Bausen M, Boobis AR, Cohen SM, Embry M, Fruijtier-Polloth C, et al. Using mode of action information to improve regulatory decision-making: an ECETOC/ILSI RF/HESI workshop overview 1. Crit Rev Toxicol. 2011;41:175–86.

    Article  PubMed  Google Scholar 

  4. Hall AP, Elcombe CR, Foster JR, Harada T, Kaufmann W, Knippel A, et al. Liver hypertrophy: a review of adaptive (adverse and non-adverse) changes—conclusions from the 3rd International ESTP Expert Workshop. Toxicol Pathol. 2012;40:971–94.

    Article  CAS  PubMed  Google Scholar 

  5. Holsapple MP, Pitot HC, Cohen SM, Boobis AR, Klaunig JE, Pastoor T, et al. Mode of action in relevance of rodent liver tumors to human cancer risk 7. Toxicol Sci. 2006;89:51–6.

    Article  CAS  PubMed  Google Scholar 

  6. Dambach DM, Andrews BA, Moulin F. New technologies and screening strategies for hepatotoxicity: use of in vitro models. Toxicol Pathol. 2005;33:17–26.

    Article  CAS  PubMed  Google Scholar 

  7. Harada T, Maronpot RR, Morris RW, Stitzel KA, Boorman GA. Morphological and stereological characterization of hepatic foci of cellular alteration in control Fischer 344 rats. Toxicol Pathol. 1989;17:579–93.

    CAS  PubMed  Google Scholar 

  8. Zimmerman HJ, Ishak KG. Hepatotoxic injury due to drugs and toxins. In: MacSween RN, Antony PP, Scheur PJ, editors. Pathology of the liver. London: Churchill Livingstone; 1979. p. 335.

    Google Scholar 

  9. Plaa GL. Toxic responses of the liver. In: Doull H, Klasse CD, Amdur MO, editors. Casarett and Doull’s toxicology. London: Macmillan; 1980. p. 206.

    Google Scholar 

  10. Zimmerman HJ. Chemical injury and its detection. In: Plaa GL, Hewitt WRP, editors. Toxicology of the liver. New York: Raven; 1982.

    Google Scholar 

  11. Jollow DJ, Mitchell JR, Zampaglione N, Gillette JR. Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite. Pharmacology. 1974;11:151–69.

    Article  CAS  PubMed  Google Scholar 

  12. Foster JR. Spontaneous and drug-induced hepatic pathology of the laboratory beagle dog, the cynomolgus macaque and the marmoset. Toxicol Pathol. 2005;33:63–74.

    Article  CAS  PubMed  Google Scholar 

  13. Gopinath C, Ford JH. The role of microsomal hydroxylases in the modification of chloroform hepatotoxicity in rats. Br J Exp Pathol. 1975;56:412–22.

    CAS  PubMed Central  PubMed  Google Scholar 

  14. Richard JD, Parker JS, Lobenhofer EK, Burka LT, Blackshear PE, Vallant MK, et al. Transcriptional profiling of the left and median liver lobes of male F344/N rats following exposure to acetaminophen. Toxicol Pathol. 2005;33:111–7.

    Article  Google Scholar 

  15. Malarkey DE, Johnson K, Ryan L, Boorman G, Maronpot RR. New insights into functional aspects of liver morphology. Toxicol Pathol. 2005;33:27–34.

    Article  CAS  PubMed  Google Scholar 

  16. Margos L, Butler WH. Effect of phenobarbitone and starvation on hepatotoxicity in rats exposed to carbon disulfide. Br J Ind Med. 1972;29:95–8.

    Google Scholar 

  17. Rouiller C. Experimental toxic injury of the liver. In: Rouiller C, editor. The liver, vol. 2. New York: Academic; 1964. p. 335.

    Chapter  Google Scholar 

  18. Butler WH. Experimental liver injury. In: MacSween RN, Antony PP, Scheur PJ, editors. Pathology of the liver. London: Churchill Livingstone; 1979. p. 55.

    Google Scholar 

  19. Gopinath C, Prentice DE, Street AE, Crook D. Serum bile acid concentration in some experimental liver lesions of rat. Toxicology. 1980;15:113–27.

    Article  CAS  PubMed  Google Scholar 

  20. Thorpe E, Gopinath C, Jones RS, Ford EJ. The effect of chloroform on the liver and the activity of serum enzymes in the horse. J Pathol. 1969;97:241–51.

    Article  CAS  PubMed  Google Scholar 

  21. Bursch W, Lauer B, Timmermann-Trosiener I, Barthel G, Schuppler J, Schulte-Hermann R. Controlled death (apoptosis) of normal and putative preneoplastic cells in rat liver following withdrawal of tumor promoters. Carcinogenesis. 1984;5:453–8.

    Article  CAS  PubMed  Google Scholar 

  22. Kerr JF. Shrinkage necrosis: a distinct mode of cellular death. J Pathol. 1971;105:13–20.

    Article  CAS  PubMed  Google Scholar 

  23. Scampini G, Nava A, Newman AJ, Della TP, Mazue G. Multinucleated hepatocytes induced by rifabutin in rats. Toxicol Pathol. 1993;21:369–76.

    Article  CAS  PubMed  Google Scholar 

  24. Jones G, Butler WH. A morphological study of the liver lesion induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats. J Pathol. 1974;112:93–7.

    Article  CAS  PubMed  Google Scholar 

  25. Denk H, Franke WW, Eckerstorfer R, Schmid E, Kerjaschki D. Formation and involution of Mallory bodies (“alcoholic hyalin”) in murine and human liver revealed by immunofluorescence microscopy with antibodies to prekeratin. Proc Natl Acad Sci U S A. 1979;76:4112–6.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  26. Ishmael J, Gopinath C, Howell JM. Experimental chronic copper toxicity in sheep. Histological and histochemical changes during the development of the lesions in the liver. Res Vet Sci. 1971;12:358–66.

    CAS  PubMed  Google Scholar 

  27. Haywood S. The effect of excess dietary copper on the liver and kidney of the male rat. J Comp Pathol. 1980;90:217–32.

    Article  CAS  PubMed  Google Scholar 

  28. Elrick MM, Kramer JA, Alden CL, Blomme EAG, Bunch RT, Cabonce MA, et al. Differential display in rat livers treated for 13 weeks with phenobarbital implicates a role for metabolic and oxidative stress in nongenotoxic carcinogenicity. Toxicol Pathol. 2005;33:118–26.

    Article  CAS  PubMed  Google Scholar 

  29. Williams GM, Iatropoulos MJ. Alteration of liver cell function and proliferation: differentiation between adaptation and toxicity. Toxicol Pathol. 2002;30:41–53.

    Article  CAS  PubMed  Google Scholar 

  30. Pruimboom-Brees IM, Brees DJJE, Shen AC, Keener M, Francone O, Amacher DE, et al. Using laser scanning cytometry to measure PPAR-mediated peroxisome proliferation and beta oxidation. Toxicol Pathol. 2005;33:86–91.

    Article  CAS  PubMed  Google Scholar 

  31. Maronpot RR, Yoshizawa K, Nyska A, Harada T, Flake G, Mueller G, et al. Hepatic enzyme induction: histopathology. Toxicol Pathol. 2010;38:776–95.

    Article  CAS  PubMed  Google Scholar 

  32. Thoolen B, Maronpot RR, Harada T, Nyska A, Rousseaux C, Nolte T, et al. Proliferative and nonproliferative lesions of the rat and mouse hepatobiliary system. Toxicol Pathol. 2010;38:5S–81.

    Article  PubMed  Google Scholar 

  33. Harada T, Maronpot RR, Morris RW, Boorman GA. Observations on altered hepatocellular foci in National Toxicology Program two-year carcinogenicity studies in rats. Toxicol Pathol. 1989;17:690–706.

    CAS  PubMed  Google Scholar 

  34. Bannasch P, Moore MA, Klimek F, Zerban H. Biological markers of preneoplastic foci and neoplastic nodules in rodent liver. Toxicol Pathol. 1982;10:19–34.

    Article  CAS  Google Scholar 

  35. Williams GM, Watanabe K. Quantitative kinetics of development of N-2-fluorenylacetamide-induced, altered (hyperplastic) hepatocellular foci resistant to iron accumulation and of their reversion or persistence following removal of carcinogen. J Natl Cancer Inst. 1978;61:113–21.

    CAS  PubMed  Google Scholar 

  36. Kushida M, Kamendulis LM, Peat TJ, Klaunig JE. Dose-related induction of hepatic preneoplastic lesions by diethylnitrosamine in C57BL/6 mice. Toxicol Pathol. 2011;39:776–86.

    Article  CAS  PubMed  Google Scholar 

  37. Maronpot RR, Harada T, Murthy AS, Boorman GA. Documenting foci of hepatocellular alteration in two-year carcinogenicity studies: current practices of the National Toxicology Program. Toxicol Pathol. 1989;17:675–83.

    CAS  PubMed  Google Scholar 

  38. Bannasch P, Bloch M, Zerban H. Spongiosis hepatis. Specific changes of the perisinusoidal liver cells induced in rats by N-nitrosomorpholine. Lab Invest. 1981;44:252–64.

    CAS  PubMed  Google Scholar 

  39. Karbe E, Kerlin RL. Cystic degeneration/spongiosis hepatis in rats. Toxicol Pathol. 2002;30:216–27.

    Article  PubMed  Google Scholar 

  40. Tatematsu M, Ho RH, Kaku T, Ekem JK, Farber E. Studies on the proliferation and fate of oval cells in the liver of rats treated with 2-acetylaminofluorene and partial hepatectomy. Am J Pathol. 1984;114:418–30.

    CAS  PubMed Central  PubMed  Google Scholar 

  41. Kang JS, Morimura K, Salim EI, Wanibuchi H, Yamaguchi S, Fukushima S. Persistence of liver cirrhosis in association with proliferation of nonparenchymal cells and altered location of alpha-smooth muscle actin-positive cells. Toxicol Pathol. 2005;33:329–35.

    Article  CAS  PubMed  Google Scholar 

  42. Low TY, Leow CK, Salto-Tellez M, Chung MC. A proteomic analysis of thioacetamide-induced hepatotoxicity and cirrhosis in rat livers. Proteomics. 2004;4:3960–74.

    Article  CAS  PubMed  Google Scholar 

  43. Nuber R, Teutsch HF, Sasse D. Metabolic zonation in thioacetamide-induced liver cirrhosis. Histochemistry. 1980;69:277–88.

    Article  CAS  PubMed  Google Scholar 

  44. Greaves P, Goonetilleke R, Nunn G, Topham J, Orton T. Two-year carcinogenicity study of tamoxifen in Alderley Park Wistar-derived rats. Cancer Res. 1993;53:3919–24.

    CAS  PubMed  Google Scholar 

  45. Klaunig JE, Babich MA, Baetcke KP, Cook JC, Corton JC, David RM, et al. PPARalpha agonist-induced rodent tumors: modes of action and human relevance. Crit Rev Toxicol. 2003;33:655–780.

    Article  CAS  PubMed  Google Scholar 

  46. Nelson LW, Kelly WA. Progestogen-related gross and microscopic changes in female beagles. Vet Pathol. 1976;13:143–56.

    CAS  PubMed  Google Scholar 

  47. Walsh KM, Rothwell CE. Hepatic effects in beagle dogs administered atorvastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, for 2 years. Toxicol Pathol. 1999;27:395–401.

    Article  CAS  PubMed  Google Scholar 

  48. Waites CR, Dominick MA, Sanderson TP, Schilling BE. Nonclinical safety evaluation of muraglitazar, a novel PPARalpha/gamma agonist. Toxicol Sci. 2007;100:248–58.

    Article  CAS  PubMed  Google Scholar 

  49. Gopinath C, Prentice DE, Lewis DJ. The liver. In: Atlas of experimental toxicological pathology. Boston: MTP Press Limited; 1987. p. 43–60.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Consultant in Toxicology and Pathology, Cambridgeshire, UK

    Chirukandath Gopinath

  2. Huntingdon Life Sciences, Cambridgeshire, UK

    Vasanthi Mowat

Authors
  1. Chirukandath Gopinath
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vasanthi Mowat
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Gopinath, C., Mowat, V. (2014). The Liver. In: Atlas of Toxicological Pathology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-998-7_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-62703-998-7_3

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-62703-997-0

  • Online ISBN: 978-1-62703-998-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation